• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ING2 基因在中国人 NSCLC 患者中的表达降低及其临床病理意义。

Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.

出版信息

Neoplasma. 2014;61(4):468-75. doi: 10.4149/neo_2014_058.

DOI:10.4149/neo_2014_058
PMID:24712846
Abstract

The inhibitor of growth 2 (ING2) is a member of lNG family, involved in cell cycle regulation, DNA repair, apoptosis and senescence, and participating in chromatin remodeling and transcriptional regulation by histone modification. Recent researches suggest ING2 plays roles in carcinogenesis both as tumor suppressor gene and ongocene depending on tumor types and cell status. Here, we investigated the status of ING2 in a series of 64 Chinese non-small cell lung cancer (NSCLC)patients using immunohistochemistry (IHC) and confirmed the results with Western blotting. RT-PCR results revealed the expression level of ING2 was consistent with mRNA level. The IHC results showed that ING2 protein expression was significantly decreased in NSCLC samples compared with normal lung tissues (P<O.OS). ING2 expression was lost in 32.8%(21/64) NSCLC tissues, which was more frequently in adenocarcinoma (ADK) than in squamous cell carcinoma (SCC), 45.8%(11124) and 26.3% (10/38), respectively. We also found ING2 translocation from the nucleus to the cytoplasm, which may bea critical event for carcinogenesis. And the status of ING2 in SCC was significantly associated with lymph node metastasis status and TNM stage. After sequencing ING2 gene, we found no heterozygosity or mutation. Taken together, these results indicated that the aberrantly expression of ING2 may contribute to NSCLC tumorigenesis.

摘要

抑生长因子 2(ING2)是 ING 家族的一员,参与细胞周期调控、DNA 修复、凋亡和衰老,并通过组蛋白修饰参与染色质重塑和转录调控。最近的研究表明,ING2 在肿瘤发生中既作为抑癌基因,也作为癌基因发挥作用,这取决于肿瘤类型和细胞状态。在这里,我们使用免疫组织化学(IHC)方法对 64 例中国非小细胞肺癌(NSCLC)患者进行了 ING2 状态研究,并通过 Western blotting 对结果进行了验证。RT-PCR 结果显示 ING2 的表达水平与 mRNA 水平一致。IHC 结果显示,与正常肺组织相比,NSCLC 样本中 ING2 蛋白表达明显降低(P<0.05)。在 64 例 NSCLC 组织中,ING2 表达缺失率为 32.8%(21/64),在腺癌(ADK)中比在鳞癌(SCC)中更常见,分别为 45.8%(11/24)和 26.3%(10/38)。我们还发现 ING2 从核内转移到细胞质,这可能是致癌的关键事件。并且 SCC 中 ING2 的状态与淋巴结转移状态和 TNM 分期显著相关。对 ING2 基因进行测序后,我们没有发现杂合性或突变。综上所述,这些结果表明 ING2 的异常表达可能导致 NSCLC 的发生。

相似文献

1
Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.ING2 基因在中国人 NSCLC 患者中的表达降低及其临床病理意义。
Neoplasma. 2014;61(4):468-75. doi: 10.4149/neo_2014_058.
2
Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.PDSS2 表达下调,一种新的肿瘤抑制因子,在非小细胞肺癌中。
Cancer Epidemiol. 2013 Apr;37(2):166-71. doi: 10.1016/j.canep.2012.12.004. Epub 2013 Jan 10.
3
Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.候选抑癌基因 ING2 在非小细胞肺癌中表达缺失。
Lung Cancer. 2010 Aug;69(2):180-6. doi: 10.1016/j.lungcan.2009.11.006. Epub 2009 Dec 4.
4
High TBX2 expression predicts poor prognosis in non-small cell lung cancer.TBX2 高表达预示非小细胞肺癌预后不良。
Neoplasma. 2014;61(4):476-80.
5
Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.人类肺癌中新型候选肿瘤抑制基因ING1和ING2的改变。
Oncol Rep. 2006 Mar;15(3):545-9.
6
Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.ING2基因在肝细胞癌中的表达降低及其临床病理意义
Cancer Lett. 2008 Mar 18;261(2):183-92. doi: 10.1016/j.canlet.2007.11.019. Epub 2007 Dec 21.
7
Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.Twist可能与缺氧非小细胞肺癌细胞的侵袭和转移有关。
Tumour Biol. 2016 Jul;37(7):9979-87. doi: 10.1007/s13277-016-4896-2. Epub 2016 Jan 27.
8
Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.非小细胞肺癌中pim-1 mRNA表达的频繁下调与淋巴结转移相关。
Oncol Rep. 2008 Sep;20(3):619-24.
9
RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.RBX1表达是非小细胞肺癌患者的不良预后因素。
Surg Oncol. 2016 Sep;25(3):147-51. doi: 10.1016/j.suronc.2016.05.006. Epub 2016 May 10.
10
Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.p53 异常导致细胞质 Ape1 表达升高可能预测可切除非小细胞肺癌的生存和复发。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S336-47. doi: 10.1245/s10434-012-2431-2. Epub 2012 Jun 12.

引用本文的文献

1
Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.利用ING2表观遗传调控作为非小细胞肺癌的治疗契机。
Cancers (Basel). 2019 Oct 21;11(10):1601. doi: 10.3390/cancers11101601.
2
The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.生长抑制因子(ING)基因在非小细胞肺癌中的生物学及临床相关性
Cancers (Basel). 2019 Aug 6;11(8):1118. doi: 10.3390/cancers11081118.
3
miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
miR-153-3p 通过抑制生长抑制蛋白 2 的表达在急性淋巴细胞白血病中发挥肿瘤抑制作用。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819852990. doi: 10.1177/1533033819852990.
4
INGs are potential drug targets for cancer.ING 蛋白是癌症潜在的药物靶点。
J Cancer Res Clin Oncol. 2017 Feb;143(2):189-197. doi: 10.1007/s00432-016-2219-z. Epub 2016 Aug 20.